Abstract
Acquired isolated hypoganglionosis is a rare intestinal neurological disease, which presents in adulthood with the clinical symptoms of chronic constipation. A 39-year-old man underwent laparoscopic low anterior resection and covering ileostomy for locally advanced-rectal cancer. A 6-month course of postoperative adjuvant chemotherapy was completed, followed by closure of the ileostoma. After the closure, he developed severe colitis which required 1-month of hospitalization. Mucosal erosions and pseudo-membrane formation were evident on colonoscopy and severe mucosal damage characterized by infiltration of inflammatory cells and crypt degeneration were pathologically confirmed. Even after the remission of the colitis, he suffered from severe constipation and distention. At 4 years after the stoma closure, he decided to undergo laparoscopic total colectomy. Histopathologically, the nerve fibers and ganglion cells became gradually scarcer from the non-dilated to dilated regions. Immunohistochemical staining examination confirmed that the ganglion cells gradually decreased and became degenerated from the normal to dilated region, thereby arriving at the final diagnosis of isolated hypoganglionosis. The patient recovered without any complications and there has been no evidence of any relapse of the symptoms. We present a case of acquired isolated hypoganglionosis-related megacolon, which required laparoscopic total colectomy, due to severe enterocolitis following stoma closure.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Isolated hypoganglionosis is a hypogenetic variant of intestinal dysganglionosis characterized by the decrease and degeneration of ganglion cells in the lamina propria in the region of the colon and rectum [1]. This rare disease represents about 3–5% of all intestinal neurological diseases, which presents with the clinical symptoms of chronic constipation and pseudo-obstruction [2]. The disease has been classified into two subtypes: congenital IHG (CIHG) and acquired IHG (AIHG) [3]. In a nationwide survey over 10 years in Japan, only eight patients were identified as having AIHG, whereas 104 patients had CIHG [4]. Because of its low incidence, the definitive concept, etiology, and histopathological criteria of AIHG remain controversial [5, 6]. Regarding the treatment of AIHG, if conservative treatment is not effective for improving the symptoms, surgery may be a promising treatment option [7]. We encountered an AIHG patient who developed marked megacolon after severe enterocolitis following the closure of a covering ileostoma and treated him successfully by laparoscopic total colectomy.
Case report
A 39-year-old man was diagnosed with locally advanced lower rectal cancer. He had no family history of bowel disease. He received preoperative chemoradiotherapy (50.4 Gy) followed by laparoscopic low anterior resection (LAR) and covering ileostomy. His postoperative course was uneventful. The final stage was determined as pT2pN1aM0 (p-Stage IIIB) after pathological examination. Adjuvant chemotherapy with XELOX over a 6month period was completed without severe adverse effects. At 7 months after LAR, the covering ileostoma was closed. On the fourth postoperative day, he developed abdominal distention with high fever and severe abdominal pain. Abdominal X-ray and CT showed remarkable bowel dilatation of the entire colon (Fig. 1), along with increased inflammation status (WBC 10,300/µL, CRP 10.3 mg/L). Colonoscopy revealed mucosal erosions and pseudo-membrane formation suspected of being pseudomembranous or cytomegalovirus-induced enterocolitis (Fig. 2). Although colonic mucosal erosion and severe inflammatory cell infiltration with crypt abscesses were evident on the biopsied samples, there were no findings detected suggestive of Clostridium difficile or cytomegalovirus infection (Fig. 3). Furthermore, there were no specific findings in the biopsied samples from the non-dilated area. Since the culture tests of the stool and blood samples were negative for any specific pathogens, he was diagnosed with severe enterocolitis of an unknown cause after stoma closure. Empirical treatment by intravenous administration of broad-range antibiotics and fasting was required for 1 month until the symptoms subsided. Even after the remission of the colitis, he suffered from severe constipation and abdominal distention. Abdominal CT scans showed wall thickening of the entire colon during the period of the severe colitis. In addition, follow-up CT examination revealed a remarkable bowel dilatation and stool retention throughout the colon at 2 months after the stoma closure. In spite of the persistent constipation, he chose for his condition to be monitored closely without any interventions. At 4 years after the stoma closure, he decided to undergo laparoscopic total colectomy to alleviate the symptoms. A trans-anal ileus tube was indwelled to improve the dilatation of the colon, which enabled us to accomplish laparoscopic total colectomy with a total operation time of 457 min and blood loss of 200 ml. The patient recovered gradually without any complications. Macroscopic findings showed marked dilatation and wall thickening of the entire colon without any mucosal lesions (Fig. 4). Histopathological examination of the resected specimen revealed that the nerve fibers and ganglion cells were intact in non-dilated area and they gradually decreased from non-dilated to dilated regions (Fig. 5a–i). In addition, some ganglion cells were degenerated in the dilated region. Immunohistochemical analysis of CD56 and S-100 showed a significant decrease in the number of neural cells in the Auerbach’s plexus.
Discussion
Hirschsprung’s disease is a widely recognized condition characterized by congenital absence of intestinal ganglia in the plexus. On the other hand, a few adults who present with the clinical symptoms of chronic constipation, pseudo-obstruction, and acute abdomen are diagnosed with an adult onset of AIHG [8, 9]. A nationwide survey over 10 years in Japan showed that only 8 (7.1%) of 112 patients with isolated hypoganglionosis were diagnosed with AIHG [3]. A challenging issue is that there is a lack of definitive diagnostic criteria and consensus on effective treatment because of the rarity of AIHG [3].
AIHG has been histopathologically characterized by decreased ganglion cells, degeneration of ganglion cells, and ganglionosis in Auerbach’s plexus [10]. More recently, a reliable method for establishing a histopathological diagnosis of AIHG has been proposed using immunohistochemical examination of S-100, Hu C/D and CD56 [11]. S-100 and Hu C/D are used as neuronal markers in both peripheral and central nerves, which facilitate the identification of individual neurons [12,13,14]. CD56, known as NCAM1 (Neural cell adhesion molecule 1), is a multifunctional glycoprotein belonging to the immunoglobulin superfamily, involved in synaptic plasticity, neurogenesis, and the development of neural circuitry [15]. In the present study, pathological and immunohistochemical evaluation including S-100 and CD56 showed a decrease in the number of and degeneration of the ganglion cells in the dilatated area (Fig. 5). Taking these pathological findings and the clinical course into consideration, we speculated that hypoganglionosis in the colon might result in substantial hypoperistalsis, leading to the chronic retention of the stool and subsequent bowel dilatation.
According to a previous report on AIHG, the patients developed the symptoms later in life with a long period of chronic constipation or intestinal pseudo-obstruction [16]. In the present case, the patient had neither past history of bowel disease nor related family history. The abdominal distention first occurred after the severe colitis. The pathological findings confirmed that this case was not congenital but acquired IHG. Congenital hypoganglionosis is characterized by impaired craniocaudal migration of neuroblasts [3]. On the other hand, AIHG has been reported to be associated with Chagas disease [5], viral infection [17], ischemia [18], and infiltration of eosinophils [11]. The infectious agents might cause a severe damage to ganglion cells, resulting in their degeneration and death [3]. However, because of its rarity, there has been no consensus on the specific cause of this disease [19,20,21]. One common event in all cases is that the intestine was severely damaged by pathogens or disorders prior to the development of the disease. In this case, stool tests at the time of severe colitis were negative for Clostridium difficile and cytomegalovirus. There was no evidence of specific bacteria or virus infection on the biopsied specimens.
Since the adjuvant chemotherapy was administered after the primary surgery in this case, the ileostoma closure was performed 7 months after the first surgery. According to a retrospective analysis on stoma closure by Rubio-Perez and colleagues, postoperative complications increased significantly when ileostoma closure was delayed [22]. In 93 patients who underwent stoma closure, the average delay of closure was 10.3 months. The most frequent postoperative complications were ileus (13%), wound infection (13%), and pseudomembranous colitis (4%). The severe colitis might result from bacterial overgrowth, the presence of harmful agents, nutritional deficiencies, and disturbance in the relationship between mucosal layer and luminal bacteria [23]. Neut and colleagues reported that there was an increase of nitrate-reducing bacteria in patients with diversion colitis [24]. Since nitrate-reducing bacteria could produce nitric oxide which is toxic to colonic tissue, high concentration of nitric oxide was supposed to play a role in the development of the diversion colitis [25]. Recently, other factors including ischemia and immune disorder were considered to cause severe colitis after stoma closure [26, 27]. A further research is needed to clarify the mechanisms underlying the diversion colitis.
With respect to cancer treatment including chemotherapy and radiotherapy, a recent study has reported that over 80% of patients treated with 5-fluorouracil developed gastrointestinal mucositis [28]. It is well documented that both radiotherapy and chemotherapy including 5-fluorouracil or oxaliplatin could cause gastrointestinal toxicities such as direct epithelial injury, tissue ischemia, villi shortening, increased crypt depth, apoptosis of intestinal epithelial cells, and bacterial translocation [28,29,30,31,32,33]. In addition, cancer treatment might have a marked effect on gut microbiota, leading to intestinal dysbiosis, mucositis, and bacterial translocation [34]. In this case, the patient received preoperative chemoradiotherapy (oral 5-fluorouracil plus 50.4 Gy) and oxaliplatin-based adjuvant chemotherapy for 6 months. Although each of these factors could cause significant histological changes in the nerve fibers and ganglion cells independently, we speculated that a complex combination of the adverse effects of these treatments, including chemotherapy and radiotherapy, and the delay of the ileostoma closure could contribute to the development of severe colitis and subsequent AIHG.
As for the treatment of adult hypoganglionosis, surgery is the definitive treatment, when conservative treatment cannot alleviate the symptoms effectively [7]. Some patients with AIHG have developed necrosis or volvulus of the bowel that required emergency open-surgery [21, 35]. In most AIHG cases, however, the conditions deteriorate quite slowly, and therefore elective surgery can be considered. Currently, laparoscopic total colectomy can be performed more safely than open surgery [36]. Furthermore, laparoscopic surgery can reduce postoperative small bowel obstruction due to fewer adhesions, which is thought to be more beneficial for relatively younger patients with AIHG. In the present case, a trans-anal ileus tube was indwelled for 2 weeks preoperatively so that the markedly dilated colon was sufficiently deflated, thereby facilitating laparoscopic total colectomy without any intraoperative problems.
We encountered a case of AIHG due to severe colitis after stoma closure. Laparoscopic total colectomy was performed safely after preoperative intestinal decompression using a trans-anal ileus tube, and the patient was able to return to ordinary daily life.
References
Dingemann J, Puri P. Isolated hypoganglionosis: systematic review of a rare intestinal innervation defect. Pediatr Surg Int. 2010;26:1111–5.
Montedonico S, Caceres P, Munoz N, et al. Histochemical staining for intestinal dysganglionosis: over 30 years experience with more than 1500 biopsies. Pediatr Surg Int. 2011;27:479–86.
Taguchi T, Masumoto K, Ieiri S, et al. New classification of hypoganglionosis: congenital and acquired hypoganglionosis. J Pediatr Surg. 2006;41:2046–51.
Taguchi T, Ieiri S, Miyoshi K, et al. The incidence and outcome of allied disorders of Hirschsprung's disease in Japan: results from a nationwide survey. Asian J Surg. 2017;40:29–34.
Iantorno G, Bassotti G, Kogan Z, et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31:460–8.
Wedel T, Roblick U, Gleiss J, et al. Disorders of intestinal innervation as a possible cause for chronic constipation. Zentralbl Chir. 1999;124:796–803.
Bentley JF. Some new observations on megacolon in infancy and childhood with special reference to the management of megasigmoid and megarectum. Dis Colon Rectum. 1964;7:462–70.
Lesser PB, El-Nahas AM, Lukl P, et al. Adult-onset Hirschsprung's disease. JAMA. 1979;242:747–8.
Martinez JP. Adult Hirschsprung's disease. Cjem. 2015;17:704–5.
Watanabe Y, Kanamori Y, Uchida K, Taguchi T. Isolated hypoganglionosis: results of a nationwide survey in Japan. Pediatr Surg Int. 2013;29:1127–30.
Yoshimaru K, Taguchi T, Obata S, et al. Immunostaining for Hu C/D and CD56 is useful for a definitive histopathological diagnosis of congenital and acquired isolated hypoganglionosis. Virchows Arch. 2017;470:679–85.
Desmet AS, Cirillo C, Vanden BP. Distinct subcellular localization of the neuronal marker HuC/D reveals hypoxia-induced damage in enteric neurons. Neurogastroenterol Motil. 2014;26:1131–43.
Phillips RJ, Hargrave SL, Rhodes BS, et al. Quantification of neurons in the myenteric plexus: an evaluation of putative pan-neuronal markers. J Neurosci Methods. 2004;133:99–107.
Amiot A, Cazals-Hatem D, Joly F, et al. The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control study. Am J Surg Pathol. 2009;33:749–58.
Oh JT, Han AR, Yang WI, et al. Morphometric evaluation of PGP9.5 and NCAM expressing nerve fibers in colonic muscle of patients with Hirschsprung's disease. Yonsei Med J. 2002;43:31–6.
Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
Holland-Cunz S, Goppl M, Rauch U, et al. Acquired intestinal aganglionosis after a lytic infection with varicella-zoster virus. J Pediatr Surg. 2006;41:e29–31.
Taguchi T, Tanaka K, Ikeda K. Fibromuscular dysplasia of arteries in Hirschsprung's disease. Gastroenterology. 1985;88:1099–103.
Aldossary MY, Privitara A, Elzamzami O, et al. A rare case of adult-onset rectosigmoid hypoganglionosis. Am J Case Rep. 2018;19:557–61.
Gabbani T, Marsico M, Marocchi M, Biagini MR. Isolated hypoganglionosis in young man with autism. Dig Liver Dis. 2017;49:104.
Qadir I, Salick MM, Barakzai A, Zafar H. Isolated adult hypoganglionosis presenting as sigmoid volvulus: a case report. J Med Case Rep. 2011;5:445.
Rubio-Perez I, Leon M, Pastor D, et al. Increased postoperative complications after protective ileostomy closure delay: an institutional study. World J Gastrointest Surg. 2014;6:169–74.
Glotzer DJ, Glick ME, Goldman H. Proctitis and colitis following diversion of the fecal stream. Gastroenterology. 1981;80:438–41.
Neut C, Guillemot F, Colombel JF, et al. Nitrate-reducing bacteria in diversion colitis: a clue to inflammation? Dif Dis Sci. 1997;42:2577–80.
McCaffeerty DM, Mudgett JS, Swain MG, et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 1997;112:1022–7.
Villanacci V, Talbot IC, Rossi E, et al. Ischemia: a pathogenetic clue in diversion colitis? Colorectal Dis. 2007;9:601–5.
Tominaga K, Kamimura K, Takahashi K, et al. Diversion colitis and pouchitis: a mini review. World J Gastroenterol. 2018;24:1734–47.
Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004;2:3–8.
Thomsen M, Vitetta L. Adjunctive treatments for the prevention of chemotherapy- and radiotherapy-induced mucositis. Integr Cancer Ther. 2018;17:1027–47.
Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clin Oncol (R Coll Radiol). 2010;22:70–83.
Stacey R, Green JT. Radiation-induced small bowel disease: latest developments and clinical guidance. Ther Adv Chronic Dis. 2014;5:15–29.
Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol. 2012;25:106–18.
Nukatsuka M, Saito H, Sakamoto K, et al. Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo. Anticancer Res. 2012;32:2807–12.
Touchefeu Y, Montassier E, Nieman K, et al. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications. Aliment Pharmacol Ther. 2014;40:409–21.
Ito T, Kimura T, Yagami T, et al. Megacolon in an adult case of hypoganglionosis, a pseudo-Hirschsprung's disease: an autopsy study. Intern Med. 2008;47:421–5.
Nakamura T, Sato T, Naito M, et al. Laparoscopic surgery is useful for preventing recurrence of small bowel obstruction after surgery for postoperative small bowel obstruction. Surg Laparosc Endosc Percutan Tech. 2016;26:e1–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Tetsuro Tominaga, Satoshi Nagayama, Manabu Takamatsu, Shun Miyanari, Toshiya Nagasaki, Tomohiro Yamaguchi, Takashi Akiyoshi, Tsuyoshi Konishi, Yoshiya Fujimoto, Yosuke Fukunaga, and Masashi Ueno declare that they have no conflict of interest.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tominaga, T., Nagayama, S., Takamatsu, M. et al. A case of severe megacolon due to acquired isolated hypoganglionosis after low anterior resection for lower rectal cancer. Clin J Gastroenterol 13, 328–333 (2020). https://doi.org/10.1007/s12328-019-01079-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-019-01079-2